Mark K Oki

CIK 1491847 · Chief Financial Officer · last filed 2026-01-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.11M

Companies

4

Total Filings

35

Lifetime Open-Market Net

-$108.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACHV Chief Financial Officer 127,940 $5.52 $706.2K -$117.3K 5 2026-01-30
AYTU Chief Financial Officer 190,000 $2.15 $408.5K $20.7K 4 2023-08-15
VIVUS INC (VVUS) Delisted Chief Financial Officer & CAO 12,100 $40.7K 11 2020-01-31
Alexza Pharmaceuticals Inc. (ALXA) Delisted Former SVP, CFO, Secretary 13,713 -$52.1K 15 2016-01-19

Recent Filings · Page 4 of 4

35 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-05-14 Alexza Pharmaceuticals Inc. (ALXA) Delisted Grant (A) +100,000 $0 EDGAR
2012-03-26 Alexza Pharmaceuticals Inc. (ALXA) Delisted Grant (A) +31,873 $0 EDGAR
2011-08-01 Alexza Pharmaceuticals Inc. (ALXA) Delisted Grant (A) $0 EDGAR
2011-05-05 Alexza Pharmaceuticals Inc. (ALXA) Delisted $0 EDGAR
2011-02-24 Alexza Pharmaceuticals Inc. (ALXA) Delisted Mixed $0 EDGAR
Showing 3135 of 35
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.